These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13353534)

  • 1. [Quantitative relationships between antigen concentration and serum titer in poliomyelitis virus neutralization test].
    DREES O; ROHDE B
    Zentralbl Bakteriol Orig; 1956 Jun; 166(2):84-9. PubMed ID: 13353534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neutralization test with Lansing poliomyelitis virus in mice and tissue cultures].
    EGGERS HJ
    Arch Gesamte Virusforsch; 1957; 7(2):136-42. PubMed ID: 13395383
    [No Abstract]   [Full Text] [Related]  

  • 3. Further experiments with the soluble antigen of the MEF1 poliomyelitis virus.
    SELZER G; VAN DEN ENDE M
    J Hyg (Lond); 1956 Mar; 54(1):1-7. PubMed ID: 13319685
    [No Abstract]   [Full Text] [Related]  

  • 4. [FREQUENCY AND TITER OF ANTIBODIES NEUTRALIZING THE 3 TYPES OF POLIOMYELITIS VIRUS IN A SAMPLE OF THE INFANTILE (1-14 YEARS) AND ADULT (21-22 YEARS) POPULATION RESIDING IN THE COASTAL PROVINCES OF TUSCANY (LUCCA, PISA, LEGHORN)].
    SANTOPADRE G; RUSCHI A; BENDINELLI M
    Riv Ital Ig; 1963; 23():283-95. PubMed ID: 14118419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Poliovirus-neutralizing antibodies in stools of poliomyelitis patients].
    Mazur B
    Przegl Epidemiol; 1971; 25(2):241-9. PubMed ID: 4328089
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of poliomyelitis antisera by plaque neutralization tests.
    FRENCH RC; ARMSTRONG RE; NAGLER FP
    Can J Microbiol; 1959 Oct; 5():461-9. PubMed ID: 13824870
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on serum from aborigines in the Northern territory of Australia. III. Antibodies against brunhilde (type I) and leon (type III) poliomyelitis viruses.
    STOKES LJ; AMES PG; MILES JA
    Med J Aust; 1955 Sep; 42(12):433-8. PubMed ID: 13264884
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the antigen-antibody reaction of in vitro neutralization of poliomyelitis virus].
    Hässelbarth A; Drees O
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):230-6. PubMed ID: 4290199
    [No Abstract]   [Full Text] [Related]  

  • 9. [COMPARATIVE ATTEMPTS TO DEMONSTRATE ANTIBODIES AGAINST POLIOMYELITIS VIRUS WITH THE NEUTRALIZATION TEST AND THE IMMUNOFLUORESCENCE METHOD].
    BOSELLA F
    Boll Ist Sieroter Milan; 1964; 43():249-52. PubMed ID: 14199041
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliomyelitis viruses in tissue culture. V. Reaction of virus and antibody; variables of the quantitative neutralization test.
    LEDINKO N; MELNICK JL
    Am J Hyg; 1953 Sep; 58(2):223-47. PubMed ID: 13080262
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antigen components of the poliovirus in the complement fixation test].
    Schmidt WA
    Ann Univ Sarav Med; 1967; 14(2):1-142. PubMed ID: 4299020
    [No Abstract]   [Full Text] [Related]  

  • 12. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic analysis of polioviruses by kinetic studies of serum neutralization.
    McBRIDE WD
    Virology; 1959 Jan; 7(1):45-58. PubMed ID: 13636055
    [No Abstract]   [Full Text] [Related]  

  • 14. The production of antibodies in cotton rats by living and killed poliomyelitis viruses.
    TOBIN JO
    Br J Exp Pathol; 1956 Apr; 37(2):161-7. PubMed ID: 13315891
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase contrast microprecipitin test with poliovirus antigens. I. Properties of the antigens and antibodies and optimum conditions for reaction.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():120-51. PubMed ID: 13725916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
    Stagni G; Merletti L; De Rosa F
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Paralytic poliomyelitis and poliomyelitis-like diseases in children].
    Leschinskaia EV; Ashmarina EE; Martynenko IN; Andreeva LS; Gracheva LA
    Pediatriia; 1979 Dec; (12):13-7. PubMed ID: 230451
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation of a non-infective antigen from preparations of poliomyelitis virus.
    AGOL VI; CHUMAKOVA MIa
    Probl Virol; 1961; 6():175-8. PubMed ID: 14036593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.